PAI-1
Le Plasminogen Activator Inhibitor-1 (PAI-1) est un inhibiteur de la sérine protéase qui régule la fibrinolyse en inhibant l'activateur tissulaire du plasminogène (tPA) et l'urokinase (uPA). Des niveaux élevés de PAI-1 sont associés à un risque accru de thrombose, de maladies cardiovasculaires et de syndrome métabolique. Les inhibiteurs de PAI-1 font l'objet de recherches pour leur potentiel dans le traitement de ces conditions. Chez CymitQuimica, nous proposons des inhibiteurs de PAI-1 pour soutenir vos recherches en hématologie, santé cardiovasculaire et maladies métaboliques.
26 produits trouvés pour "PAI-1"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Upamostat
CAS :Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor.Formule :C32H47N5O6SDegré de pureté :99.41%Couleur et forme :SolidMasse moléculaire :629.81Ref: TM-T13257
1mg64,00€2mg94,00€5mg145,00€10mg226,00€25mg379,00€50mg538,00€100mg730,00€1mL*10mM (DMSO)163,00€Angstrom6
CAS :Angstrom6 (A-6 peptide) is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascadeFormule :C39H62N10O15Degré de pureté :99.36%Couleur et forme :SolidMasse moléculaire :910.97CT140
CT140 is a human IgG4 monoclonal antibody (mAb) that specifically targets PAI-1. The suggested isotype control for this compound is Human IgG4 kappa, Isotype Control.Couleur et forme :Odour LiquidGGACK hydrochloride
GGACK (H-Glu-Gly-Arg-CMK) hydrochloride is an irreversible substrate-like inhibitor of the serine protease urokinase-type plasminogen activator (uPA).
Formule :C14H26Cl2N6O5Couleur et forme :SolidMasse moléculaire :428.13417Nattokinase
CAS :Nattokinase is a serine protease derived from nattō, oral， fibrinolytic/anticoagulant properties. It degrades fibrin, fibrinolytic substrates, and PAI-1.Couleur et forme :SolidUK140
UK140 is an inhibitor of the urokinase-type plasminogen activator (uPA), with Ki values of 0.20 µM for human uPA (huPA) and 2.79 µM for mouse uPA (muPA). UK140 is applicable in studies related to tumor metastasis.Formule :C72H105N19O25S3Couleur et forme :SolidMasse moléculaire :1732.91Bicyclic UK18
CAS :Bicyclic UK18 is a competitive inhibitor of human urokinase-type plasminogen activator (uPA) with a Ki value of 53 nM.Formule :C77H118N26O25S3Couleur et forme :SolidMasse moléculaire :1904.116-Aminocaproic acid (Standard)
CAS :6-Aminocaproic acid (Standard) is the standard substance of 6-Aminocaproic acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. 6-Aminocaproic acid (EACA) is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.Formule :C6H13NO2Couleur et forme :Fine White Crystalline Powder SolidMasse moléculaire :131.17TM5441
CAS :TM5441 is an orally bioavailable fibrinogen activator inhibitor-1 inhibitor that inhibits several cancer cell lines with IC50 values ranging from 13.9 to 51.1 μM.Cost-effective and quality-assured.Cost-effective and quality-assured.Formule :C21H17ClN2O6Degré de pureté :97.62% - 99.09%Couleur et forme :SolidMasse moléculaire :428.82Tiplaxtinin
CAS :Tiplaxtinin (Tiplasinin)(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.
Formule :C24H16F3NO4Degré de pureté :99.16% - 99.93%Couleur et forme :SolidMasse moléculaire :439.38UK-371804
CAS :UK-371804: potent uPA blocker; candidate for chronic skin ulcer preclinical studies.Formule :C14H16ClN5O4SDegré de pureté :95.81% - 99.77%Couleur et forme :SolidMasse moléculaire :385.83Ref: TM-T3442
1mg49,00€2mg63,00€5mg103,00€10mg170,00€25mg306,00€50mg460,00€100mg668,00€500mg1.395,00€1mL*10mM (DMSO)111,00€Loureirin B
CAS :Loureirin B suppresses fibrosis by modulating MMPs/TIMPs, hindering fibroblast growth, and targeting TGF-β1/Smad2/3 pathway.Formule :C18H20O5Degré de pureté :99.33% - 99.86%Couleur et forme :SolidMasse moléculaire :316.35TM5007
CAS :TM5007 is a poent inhibitor of plasminogen activator inhibitor-1 (PAI-1; IC50 of 29 uM).Formule :C24H20N2O6S4Degré de pureté :96.91%Couleur et forme :SolidMasse moléculaire :560.69TM5275 sodium
CAS :TM5275 sodium (TM5275 sodium salt) is an inhibitor of plasminogen activator inhibitor 1 (PAI-1).Formule :C28H27ClN3NaO5Degré de pureté :98.8% - 99.74%Couleur et forme :SolidMasse moléculaire :543.98Ref: TM-T4255
2mg39,00€5mg62,00€10mg93,00€25mg160,00€50mg231,00€100mg334,00€200mg465,00€1mL*10mM (DMSO)67,00€Toddalolactone
CAS :Toddalolactone ((+)-Toddalolactone) is an anti-inflammatory and analgesic.Formule :C16H20O6Degré de pureté :99.8% - 99.85%Couleur et forme :SolidMasse moléculaire :308.33Ref: TM-T4S0592
2mg37,00€5mg52,00€10mg73,00€25mg105,00€50mg152,00€100mg215,00€200mg320,00€1mL*10mM (DMSO)63,00€MDI-2268
CAS :MDI-2268, an inhibitor of plasma kallikrein inhibitor 1 (PAI-1), exhibits strong antithrombotic properties. It plays a role in regulating blood coagulation by promoting fibrinolysis and is applicable in research related to deep vein thrombosis.Formule :C10H10F3N3O3Couleur et forme :SolidMasse moléculaire :277.20Diaplasinin
CAS :Diaplasinin (PAI-749) is a potent inhibitor of plasminogen activator inhibitor-1 (PAI-1) with antithrombotic activity, used in cardiovascular disease research.Formule :C32H31N5ODegré de pureté :99.02%Couleur et forme :SolidMasse moléculaire :501.62Ref: TM-T25915
1mg57,00€5mg120,00€10mg178,00€25mg409,00€50mg708,00€100mg1.153,00€1mL*10mM (DMSO)133,00€UK-371804 HCl
CAS :UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (2700-Formule :C14H17Cl2N5O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :422.29SK-216
CAS :SK-216,PAI-1 inhibitor. Reduces tumor angiogenesis. Inhibits VEGF-induced endothelial cell migration. Alleviates pulmonary fibrosis.Formule :C29H29NNa2O6Degré de pureté :98.29%Couleur et forme :SolidMasse moléculaire :533.52p-Aminobenzamidine dihydrochloride
CAS :4-Aminobenzamidine dihydrochloride (p-Aminobenzamidine dihydrochloride) is a strong trypsin inhibitor and a relatively weak inhibitor of urokinase typeFormule :C7H11Cl2N3Degré de pureté :99.00% - 99.56%Couleur et forme :SolidMasse moléculaire :208.088
